Background: There is growing interest in the potential of artificial intelligence (AI) to support decision making in health and social care settings. There is, however currently limited evidence of the effectiveness of these systems.
message surrounding effectiveness will emerge -rather effectiveness of interventions is likely to be context specific.
Background
There is now an increasing focus on health information technology (HIT) to improve the quality, safety and efficiency of care, to tackle demographic shifts, variations in the quality of care, and ongoing concerns around safety, and cope with increasing economic pressures. (1) There is a growing empirical evidence base that knowledge-based computerised decision support (CDS), and in particular knowledge-based Clinical Decision Support Systems which form a subcategory of these, have the potential to improve practitioner performance.(2,3) Such technologies commonly draw on an existing knowledge base of existing research evidence and/or guidelines to provide logical reasoning-based expert advice. Knowledge-based CDS is different from data-driven CDS in that it does not involve the creation of new knowledge.
Recent reviews have shown that artificial intelligence (AI) algorithms in digital health interventions can be effective in improving health outcomes across a range of conditions but none has focused on data-driven CDS systems. (4, 5) These systems are designed to emulate human performance typically by analysing large complex datasets. There are now over 16 AI-based products approved by the United States (US) Food and Drug Administration (FDA). 1 There is growing interest from the public, health service providers, policymakers, system vendors, the media and funding bodies, in the potential of CDS linked to data-driven AI-based algorithms as these can help to quantify risk and facilitate human decision making. However, there has to date been no systematic attempt to scope the empirical evidence base in relation to the effectiveness of CDS systems linked to data-driven AI-based algorithms and some have cautioned against the hype associated with AI-based technologies used in healthcare delivery. (6, 7) We aimed to investigate the effectiveness of data-driven AI to support decision making in health and social care settings.
Methods

Design
We undertook a systematic review of published empirical research. The systematic review protocol is registered with the PROSPERO International Prospective Register of Systematic Reviews and reported 1 https://medium.com/syncedreview/ai-powered-fda-approved-medical-health-projects-a19aba7c681 using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. (8, 9) We used the PICO framework to form the research questions and to focus the literature search (see Table 1 ). 
Eligibility criteria
Studies were eligible for inclusion if they were conducted in health and social care settings and published in English; if they focused on AI; and if they used technological systems for clinical, managerial and self-management decision making.
Studies were excluded if they were not RCTs or if they fell outside our scope of interest. This included, for example, studies that evaluated technology that is not commonly associated with systems that are driven by the analysis of patterns and models emerging from very large datasets, and those that did not focus on a combination of CDS and AI.
Study selection
Titles and abstracts of studies identified from the searches were screened by two investigators (MC and SK for abstracts, MC and ZS for full texts), who screened all retrieved potentially eligible studies independently against the above criteria. Any disagreements were resolved by discussion or, if necessary, through arbitration by KC. 
Quality assessment and analysis
Data analysis
A quantitative synthesis was judged to be inappropriate due to the heterogeneity of technologies being assessed and care contexts. Data were therefore descriptively summarised and narratively synthesised. We followed the following steps in conducting an interpretive synthesis of our findings:
(1) describing the various functions of technological systems; (2) noting the context of the various studies and settings; (3) summarising evidence of effectiveness; and (4) summarising study quality.
Results
We identified 69 potentially eligible studies. After removing duplicates, we screened 68 abstracts. At screening stage, 31 abstracts were dropped. Most excluded abstracts (n=16) did not include AI. Study protocols (n=10) and non-randomized studies (n=10) were also excluded. We assessed 37 full-text articles for eligibility, from which 32 were excluded. Ineligible articles did not combine AI and CDS functionality (n=15), did not have AI as their primary focus (n=7), did not have RCT designs (n=6), did not report our outcomes of interest (n=2), or did not have interventions that were data-driven (n=2) were excluded.
Five papers were included in final review ( Figure 1 ). Of these, two were conducted in the US, one in Spain, one in Denmark, and one in the United Kingdom. Two included RCTs were conducted in inpatient settings, two in a home care setting, and one in an outpatient setting. Key characteristics of included studies are summarised in Table 2 . Variation in study size, technological systems, timescales
We observed substantial variations in the size of studies (from 28 to 47062 participants), technological systems (i.e. type of AI-based CDS) and timescales over which the systems were assessed. (12) (13) (14) (15) (16) All included studies focused on specific patient populations (often with long-term conditions), namely:
women with gestational diabetes,(12) women in labour, (14) , adults with ischemic stroke, (15) thrombosis patients, (16) and lung transplant recipients. (13) Types of AI facilitated decision support also varied widely. One study assessed learning algorithms to support patient self-management; (12) another study assessed algorithms facilitating automated triaging based on existing datasets; (13) and another study assessed algorithms facilitating the interpretation of fetal cardiotocographs (CTGs) through image pattern recognition. (14) The final two studies assessed the use of neural networks to facilitate medication adherence, (15) and the Kalman filter technique (an algorithm using temporal measurements) to personalise warfarin dosing recommendations for patient self-management. (16) Three studies investigated decision making in patients, (12, 15, 16) whereas the others focused on decision making in healthcare professionals. (13, 14) We further found large variations in timescales of studies from 12 weeks to 3.5 years in duration. (14, 15) 
Patient outcomes needed
In terms of outcomes, studies most frequently assessed impact of the intervention on patient outcomes, but these varied significantly across RCTs due to the differences in study populations. For 
Quality assessment
The quality of studies was extremely variable. Details of methods were in some instances difficult to find and only one study used a double-blind design. (13) In another study, only patients were blinded, (16) another one used no blinding, (14) and for the remaining two it was unclear whether blinding took place. (12, 15) We provide a risk of bias table below (Table 3 ). 
Mixed evidence of effectiveness
Evidence of effectiveness was mixed, with two studies showing no statistically significant difference to the control group, (13, 14) and two showing statistically significant and clinically relevant differences between the intervention and the control groups. (12, 15, 16) Detailed study characteristics and outcomes are provided in Table 2 .
One study with high risk of bias, focussing on a learning algorithm to help with managing gestational diabetes reported positive findings. It showed a decrease in assessment time (from 15 minutes in the control group to 2.778 ± 0.858 minutes in the intervention group per patient), and a reduction in faceto-face consultations (3.207 ± 2.846 visits in the control group and 0.367 ± 0.901 in the intervention group). (12) Another study, also with high risk of bias, using computer vision and neural networks reported that the mean cumulative medication adherence indicated by plasma drug concentration was 100% for the intervention and 33% for the control group. (15) Other RCTs with low risk of bias showed no difference. 
Discussion
Overall, the evidence of effectiveness of AI to support decision making in health and social care settings is limited. We found a very small number of relevant studies with large variability in quality, settings, outcomes and technologies. No identified studies were conducted in social care settings and none included work investigating any enablers and/or barriers for the use of data-driven AI to support decisions. Three RCTs showed no difference, whereas two showed statistically significant and clinically relevant differences to the control groups.
Strengths and limitations
Our review is a first of type examining the use of data-driven AI to support decision making. However, as we have shown, the number of potentially relevant RCTs is limited, perhaps reflecting the immaturity of the field, but also potentially due to overlapping definitions surrounding CDS and AI. For example, it was at times hard for the research team to distinguish between knowledge-driven and data-driven applications. Moreover, the conclusions that can be drawn from this work are limited as all included studies compared AI-based CDS with standard care. Ideally, the comparison should be AIenabled CDS versus CDS to see if AI makes a difference to standard knowledge-based CDS.
Integration of findings with the current literature
The lack of eligible studies may call for widening the search criteria to include different methodologies to assess the effectiveness of data-driven AI algorithms to support decision making in health and social care settings. (17) Nevertheless, despite these perhaps inevitable challenges, we have helped to provide a starting point for work in this area going forward. There is a need to look at potential unintended consequences and challenges associated with novel systems in combination with RCTs.(18) Concurrent qualitative evaluation can help to address some of these issues and also help to identify contextual dynamics and potential reasons for effectiveness (or lack thereof). (19) It may be that the lack of existing RCTs in the area is due to issues with data access for AI specialists. (20) This may also help to explain the involvement of system developers in 50% of our included studiesthey may have had privileged access to data in their systems. The more data algorithms can draw on, the more effective they become, but access to large curated datasets on which algorithms can be trained is currently still hard to achieve. (19, 20) More generally, there is a need to remember that, as in knowledge-driven CDS, the ultimate responsibility of the decision still lies with the human. As such, those at the receiving end of datadriven AI based CDS need to be trained to make decisions informed by these systems. This may require developing new skills and/or ways of considering evidence. (21) Policy recommendations and implications for practice emerging from this work Our work may support those cautioning against the assumed effectiveness of AI and the associated hype surrounding these technologies. (7) Policymakers need to be aware that evidence of effectiveness is limited at this stage. In order to address the variability of existing work in this area, strategic decision makers may need to extract key areas of focus for research and innovation within their locales where applications have the greatest potential to meet a major service need and where they are most likely to deliver real impact. Ideally, these should be designed to be comparable in terms of technologies and disease areas, and include qualitative formative evaluation components to capture emerging challenges. The limited details reported in the methods sections of included studies, particularly in relation to AI algorithms, also calls for clearer standards of reporting of studies to ensure rigour and independent assessment of risk of bias.
As the application of AI is gaining momentum, there is likely to be an increasing need for developing associated evaluation frameworks, reporting guidelines and understanding transferability beyond experimental contexts. A focus on unintended consequences, positive or negative, should be fundamental to these efforts.
Conclusions
AI-based data-driven decision making in healthcare settings may have significant potential. Two of the trials included in this work showed substantial gains, but there are concerns in relation to the quality of these studies. Search modes -Boolean/Phrase S14 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13
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